Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 7529 - 7536 of 12099 results
21st Century Cures Act – Med Tech Impact Webinar January 18
December 21, 2016| Blog| Viewpoint
USPTO Proposes Fee Increases for FY 2017
December 21, 2016| Blog| Viewpoint
Rules of the Road for Using Experts in International Arbitration
December 21, 2016| News
The Definition of Insanity? Wendy’s Shareholders File Derivative Action Based on 2015-16 Data Breach
December 20, 2016| Blog| Viewpoint
Regulation Crowdfunding: A Six-Month Update
December 20, 2016| News
Arbitration Agreements – Incorporation by Reference of an Arbitration Clause in Another Document Is a Simple Matter . . . isn’t it?
December 19, 2016| Blog| Viewpoint
Pros and Cons of Hot Tubbing in International Arbitration
December 19, 2016| Blog| Viewpoint
Multi-Step ADR: Drafting Sensible and Effective Dispute Resolution Provisions
December 19, 2016| Blog| Viewpoint
News & Press Releases
Mintz Advises Underwriters in Assembly Biosciences' $175 Million Underwritten Offering and Concurrent Private Placement
August 18, 2025
Mintz advised the underwriters in connection with Assembly Biosciences, Inc.’s underwritten offering of an aggregate of 5,591,840 shares of common stock and pre-funded warrants to purchase up to 1,040,820 shares of common stock, together with accompanying Class A and Class B warrants to purchase up to an aggregate of 6,632,660 shares of common stock at a combined price per share of common stock and accompanying Class A warrant and Class B warrant of $19.60 and a combined price per pre-funded warrant and accompanying Class A warrant and Class B warrant of $19.599.
Mintz Advises on Ondas Holdings’ $173 Million Public Offering
August 18, 2025
Mintz advised the underwriter in connection with the $173 million public offering by Ondas Holdings Inc. of 53,084,000 shares of its common stock, which includes 6,924,000 shares of common stock sold pursuant to the exercise in full by the underwriter of their over-allotment option. Ondas Holdings, Inc. is a leading provider of private industrial wireless networks and commercial drone and automated data solutions. Ondas intends to use the net proceeds of the offering for working capital, general corporate purposes and potential strategic transactions, including acquisitions of businesses or assets, joint ventures or investments in businesses, products or technologies.
Mintz Advises on Equillium, Inc.'s up to $50 Million PIPE
August 15, 2025
Mintz advised the lead placement agent in connection with an up to $50 million private placement by Equillium, Inc. The PIPE was comprised of (i) an initial upfront closing of approximately $30 million in gross proceeds in exchange for approximately 52.6 million shares of common stock (or, for certain investors, pre-funded warrants in lieu of common stock), and (ii) the potential for up to an additional $20 million in gross proceeds in exchange for up to approximately 35.1 million shares of common stock (or, for certain investors, pre-funded warrants in lieu of common stock), subject to achieving specified milestones related to clinical study initiation and share price.
Events
Podcasts
Mintz On Air: Practical Policies - Investigations Unscripted
August 12, 2025| Podcast|
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|